Exelixis (EXEL) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 26, 2026, with virtual participation available for shareholders.

• Shareholders are encouraged to review proxy materials and vote by May 25, 2026.

Voting matters and shareholder proposals

• Election of eleven director nominees to serve until the next annual meeting.

• Ratification of Ernst & Young LLP as independent auditor for the fiscal year ending January 1, 2027.

• Amendment and restatement of the 2017 Equity Incentive Plan to increase authorized shares by 2,000,000.

• Advisory vote on executive compensation (say-on-pay) for named executive officers.

• Provision for other business to be addressed as may properly come before the meeting.

Board of directors and corporate governance

• Eleven nominees listed for election, including individuals with diverse backgrounds in science, medicine, and business.